Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$184B
P/E ratio
27×
Div yield
0.4%
EPS (TTM)
$18.19
Profit margin
15%
Rev. growth
+6%
Revenue
$45B
Gross margin
41%
In plain English
Thermo Fisher is the picks-and-shovels giant of life science: it sells the cell-culture media, single-use bioreactors, reagents, lab plastics and analytical instruments that nearly every drugmaker, hospital lab and university runs on — and, through PPD and Patheon, runs the clinical trials and contract-manufactures the medicines themselves. Built by decades of huge takeovers, it touches almost every step of getting a drug from bench to patient.
In simple terms
What Thermo Fisher Scientific really sells
Thermo Fisher is the picks-and-shovels giant of life science: it sells the cell-culture media, single-use bioreactors, reagents, lab plastics and analytical instruments that nearly every drugmaker, hospital lab and university runs on — and, through PPD and Patheon, runs the clinical trials and contract-manufactures the medicines themselves. Built by decades of huge takeovers, it touches almost every step of getting a drug from bench to patient.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.